review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1080/13506129.2017.1416350 |
P698 | PubMed publication ID | 29241368 |
P50 | author | Moshe E Gatt | Q87811200 |
Irit Avivi | Q87833182 | ||
Yael C Cohen | Q88232125 | ||
Adir Shaulov | Q89637740 | ||
P2093 | author name string | Merav Leiba | |
Adrian Duek | |||
P2860 | cites work | Duodenal perforation in primary systemic amyloidosis | Q43221496 |
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. | Q44254874 | ||
Spontaneous pneumoperitoneum: an unusual complication of systemic reactive AA amyloidosis secondary to rheumatoid arthritis | Q44450464 | ||
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes | Q44572498 | ||
Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis | Q47815811 | ||
A case of caecal perforation treated by laparoscopic caecectomy - a video vignette | Q48351947 | ||
Liver transplantation in transthyretin familial amyloid polyneuropathy: first report from Argentina. | Q51978988 | ||
Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series. | Q52992225 | ||
Sensitivity to Quorn mycoprotein (Fusarium venenatum) in a mould allergic patient | Q24672968 | ||
Gastrointestinal Manifestations of Amyloidosis | Q29400172 | ||
Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing | Q32111479 | ||
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis | Q33629374 | ||
Amyloidosis--an unusual case of recurrent intestinal bleeding and sigmoid perforation: case report with review of the literature | Q33831802 | ||
Immunomodulatory drugs in multiple myeloma | Q34325722 | ||
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma | Q34450381 | ||
Perforation of the sigmoid colon and massive ischemia of the small intestine caused by amyloidosis associated with multiple myeloma: a case report | Q34623627 | ||
PERFORATION OF SMALL BOWEL IN AMYLOIDOSIS; INCLUDES REVIEW OF THE LITERATURE. | Q35464079 | ||
Adverse effects of thalidomide administration in patients with neoplastic diseases | Q35909155 | ||
Thalidomide and lenalidomide in the treatment of multiple myeloma | Q36496138 | ||
Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy | Q37118108 | ||
Perforation of rectal diverticulum with amyloidosis secondary to rheumatoid arthritis: case report and review of the literature | Q38550280 | ||
Pneumatosis intestinalis due to gastrointestinal amyloidosis: A case report & review of literature | Q38809859 | ||
Immunoglobulin Light Chain Systemic Amyloidosis | Q38970608 | ||
Amyloidosis and the gut | Q39972227 | ||
Free perforation of the small intestine | Q40841344 | ||
The systemic amyloidoses | Q41596634 | ||
Colonic perforation by amyloidosis. Report of a case | Q41980226 | ||
Selective massive amyloidosis of small intestine | Q42067497 | ||
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial | Q43109172 | ||
P433 | issue | 1 | |
P304 | page(s) | 11-17 | |
P577 | publication date | 2017-12-14 | |
P1433 | published in | Amyloid | Q4749545 |
P1476 | title | Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literature | |
P478 | volume | 25 |
Search more.